Evidence map›Paper›PMID 35027650›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022

Correction to: Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.

Chisato Ohe, Takashi Yoshida, Mahul B Amin, Naho Atsumi, Junichi Ikeda, Kazuho Saiga, Yuri Noda, Yoshiki Yasukochi, Riuko Ohashi, Haruyuki Ohsugi and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Chisato OheDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan. ohec@hirakata.kmu.ac.jp.
Takashi YoshidaDepartment of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Mahul B AminDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, 930 Madison Avenue, Memphis, TN, 38163, USA.
Naho AtsumiDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Junichi IkedaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Kazuho SaigaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Yuri NodaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Yoshiki YasukochiGenome Analysis, Institute of Biomedical Science, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Riuko OhashiHistopathology Core Facility, Faculty of Medicine, Niigata University, Niigata, 951-8510, Japan.
Haruyuki OhsugiDepartment of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Koichiro HigasaGenome Analysis, Institute of Biomedical Science, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Hidefumi KinoshitaDepartment of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.
Koji TsutaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35027650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.